Veropharm (Abbott Group) CEO and the Governor of the Vladimir Region announced the launch of two new production lines for sterile injectable drugs at Volginsky plant. The opening ceremony took place in accordance with the agreement reached by the parties at the St. Petersburg International Economic Forum.
Medicines that will be produced here are included in the list of vital and essential medicines (Vital and Essential Drugs), designed to provide medical care in hospitals in such therapeutic areas as anesthesiology and intensive care, oncology, hematology, neurology, cardiology, gastroenterology. These medicines are necessary for hospitals to treat patients with malignant neoplasms, chronic renal failure, liver diseases, cardiovascular diseases, as well as for medical support of surgical interventions.
The capacity of new production sites can reach over 50 million ampoules and vials per year. As part of the opening of new lines for representatives of the Ministry of Health, the Ministry of Industry and Trade and the Vladimir Administration, a tour of the plant was conducted. The guests got acquainted with modern equipment and the technological process in the production that meets high international standards.